Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy.
Conteduca V, Caffo O, Scarpi E, Sepe P, Galli L, Fratino L, Maines F, Chiuri VE, Santoni M, Zanardi E, Massari F, Toma I, Lolli C, Schepisi G, Sbrana A, Kinspergher S, Cursano MC, Casadei C, Modonesi C, Santini D, Procopio G, De Giorgi U. Conteduca V, et al. Among authors: sbrana a. J Clin Med. 2020 Jun 22;9(6):1950. doi: 10.3390/jcm9061950. J Clin Med. 2020. PMID: 32580478 Free PMC article.
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.
Del Re M, Crucitta S, Restante G, Rofi E, Arrigoni E, Biasco E, Sbrana A, Coppi E, Galli L, Bracarda S, Santini D, Danesi R. Del Re M, et al. Among authors: sbrana a. Crit Rev Oncol Hematol. 2018 May;125:51-59. doi: 10.1016/j.critrevonc.2018.03.002. Epub 2018 Mar 6. Crit Rev Oncol Hematol. 2018. PMID: 29650277 Review.
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer.
Del Re M, Crucitta S, Sbrana A, Rofi E, Paolieri F, Gianfilippo G, Galli L, Falcone A, Morganti R, Porta C, Efstathiou E, van Schaik R, Jenster G, Danesi R. Del Re M, et al. Among authors: sbrana a. BJU Int. 2019 Oct;124(4):693-700. doi: 10.1111/bju.14792. BJU Int. 2019. PMID: 31055861
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.
Pasqualetti F, Panichi M, Sollini M, Sainato A, Galli L, Morganti R, Chiacchio S, Marciano A, Zanca R, Mannelli L, Coraggio G, Sbrana A, Cocuzza P, Montrone S, Baldaccini D, Gonnelli A, Molinari A, Cantarella M, Mazzotti V, Ricci S, Paiar F, Erba PA. Pasqualetti F, et al. Among authors: sbrana a. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):185-191. doi: 10.1007/s00259-019-04482-6. Epub 2019 Oct 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 31620808 Free PMC article.
Muscle function impairment in cancer patients in pre-cachexia stage.
Dalise S, Tropea P, Galli L, Sbrana A, Chisari C. Dalise S, et al. Among authors: sbrana a. Eur J Transl Myol. 2020 Jun 22;30(2):8931. doi: 10.4081/ejtm.2019.8931. eCollection 2020 Jul 13. Eur J Transl Myol. 2020. PMID: 32782760 Free PMC article.
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone.
Crucitta S, Del Re M, Paolieri F, Bloise F, Sbrana A, Sammarco E, Mercinelli C, Cucchiara F, Fontanelli L, Galli L, Danesi R. Crucitta S, et al. Among authors: sbrana a. Cancer Chemother Pharmacol. 2020 Oct;86(4):527-533. doi: 10.1007/s00280-020-04133-w. Epub 2020 Sep 18. Cancer Chemother Pharmacol. 2020. PMID: 32945940
Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study.
Procopio G, Chiuri VE, Giordano M, Mantini G, Maisano R, Bordonaro R, Calvani N, Facchini G, De Placido S, Airoldi M, Sbrana A, Gasparro D, Ludovico GM, Guglielmini P, Naglieri E, Fagnani D, Aglietta M, Schips L, Beccaglia P, Sciarra A, Livi L, Santini D. Procopio G, et al. Among authors: sbrana a. Ther Adv Med Oncol. 2020 Oct 29;12:1758835920968725. doi: 10.1177/1758835920968725. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33193831 Free PMC article.
93 results